Fig 1: RGS5 is necessary for astrocytic TNFRs-promoted inflammatory factor expression with TNF-α/LPS challenge. A Double immunofluorescence staining for GFAP and TNFR1 or TNFR2 on the substantia nigra (SN). Arrows indicate the double-labeled cells. Scale bars, 5 μm. B ELISA analysis showing increased secretion of TNF-α in primary cultured astrocytes overexpressing TNF receptors mediated by lentivirus following exposure to TNF-α. The cells were incubated with TNF-α (100 ng/ml) for 1 h, and then washed 3 times with DMEM. Then, the culture medium was replaced with fresh DMEM containing 10% FBS and collected for ELISA 4 h later (n = 6). C, D Representative Western blots (C) and quantifications (D) showing endogenous TNF-α and pro-IL-1β protein expression in primary cultured astrocytes overexpressing GFP, TNFR1 or TNFR2 mediated by lentivirus transfection following exposure to TNF-α or vehicle for 5 h. The cells were washed three times with PBS before lysed. TNF-α 100 ng/ml, 5 h, n = 7. E–H Representative Western blots showing the reduction of TNF-α and pro-IL-1β protein levels in Rgs5-null (RGS5hGFAP) astrocytes. Primary astrocytes were transfected with Lentivirus (LV-GFP, LV-TNFR1 or LV-TNFR2) followed by challenge with either TNF-α (100 ng/ml) (E, F) or LPS (500 ng/ml) (G, H). n = 3–5. Data are expressed as mean ± SEM, two tailed t-test. *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001
Fig 2: TNFα secreted by GAMs induces EC activation and associates with OS in human GBM. a CM from Mφ-NHA, Mφ-U87, Mφ-U118, Mφ-U251, or Mφ-A172 was analyzed by a multi-analyte inflammatory ELISA array or b concentrated and immunoblotted with anti-TNFα. Total protein was detected using PageBlue. c TNFα ELISA with CM from Mφ-NSC, Mφ-GSC28 or Mφ-GSC267 was performed to validate the results found in the GBM cell lines. d Human cerebral endothelial cells (hCMEC/D3) were incubated with or without 10 ng/mL hTNFα for 24 h and gene expression was analyzed on an RT-PCR angiogenesis array. Relative quantity was calculated by normalizing to –TNFα. n = 3, mean ± max/min, 95% confidence interval *p < 0.05, **p < 0.01, ***p < 0.001. e Representative image of human GBM tissue section co-stained with TNFα (blue) and CD68 (red), double positive cells (arrow). f Representative image of human GBM tissue section co-stained with TNFα (blue) and VCAM1 (red). Scale bar = 50 µm. g. Correlation between extent of VCAM1 staining (Low, Medium or High) and percentage of TNF-alpha expressing GAMs cells per mm2 tumor area was performed in 39 IDH-wt GBM tissues. Log2 transformation was performed on the values of percentage of TNF-alpha expressing GAMs cells per mm2 tumor area (R = 0.8, p = 2.738e-009). h. Correlation of expression between CD68 and TNFα was analyzed in 137 IDH-wt GBM, R = 0.46, p = 1.93E-08 (lower panel), Kaplan–Meier survival curve of 137 IDH-wt GBM grouped by high or low CD68 and TNFα expression, p = 0.027 (upper panel)
Fig 3: Proteins and mRNA expression of TNF-α, TNFR1, caspase-8 and caspase-3 are significantly reduced in IgAN mouse kidneys. (A) Western blotting results and (B) relative protein expression of TNF-α and TNFR1. (A) Western blotting results and (C) relative protein expression of caspase-8 and caspase-3. (D) Transcription levels of TNF-α and TNFR1 (n = 3). (E) Transcription levels of caspase-8 and caspase-3 (n = 3). Data are expressed as mean ± SD for groups of 20 mice. *p < 0.05, **p < 0.01 vs. control group. TNFR1, TNF receptor 1; IgAN, IgA nephropathy.
Fig 4: NF-κBp65, COX-2, TNF-α, IL-1β and iNOS protein expression levels (A-B) Effects of F-AOH on the protein expression of NF-κBp65, TNF-α, IL-1β, COX-2, and iNOS in gastric tissues. (C–G) Quantification of the relative protein levels of NF-κBp65, TNF-ℵ, IL-1β, COX-2, and iNOS. **p < 0.01 compared with ethanol group; #p < 0.05 and ##p < 0.01 compared with ethanol group.
Fig 5: B cells from RA patients inhibit OB differentiation. a–c Peripheral blood (PB) B cells were purified, as in Fig. 2A and stimulated (S) with CpG2006+anti-Ig (A+G+M) Ab or vehicle (U) for 4 h. a CCL3 and TNF mRNA expression was detected by qPCR. *p < 0.05. b CCL3 and TNF protein expression levels were assessed in the culture media by ELISA. *p < 0.05. c Conditioned medium (40% by volume) from B cell culture were co-cultured with human MSCs ± anti-CCL3 neutralizing Ab ± anti-TNF neutralizing Ab in OB-inducing medium for 3 days. ALP+ area was measured. *p < 0.05 vs. U, #p < 0.05 vs. S-IgG. d PB B cells from RA patients and healthy controls (HC) were co-cultured with human MSCs in OB-inducing medium for 3 days. ALP staining was performed. *p < 0.05 vs. HC. e The expression levels of ALP and Runx2 in hMSCs in d were measured by qPCR. Fold-changes were calculated by dividing patient values by the value from HC cells. Values represent individual HC/RA. *p < 0.05 vs. HC. f RA synovium was stained with Abs to CD20 (B cells), CCL3 and TNF. White arrows indicate the cells with dual staining. Bar = 25 μm. 3 or 6 patients and their controls were included in each experiment. All of these experiments were repeated at least once with representative images and quantifications shown. All error bars represent s.e.m. One way ANOVA followed by Dunnett’s post-hoc multiple comparisons was performed for c. Two-tailed unpaired Student’s t-test was performed for all the others
Supplier Page from Abcam for Anti-TNF alpha antibody